There are 2867 resources available
CN39 - Development of a reference model for patient and public involvement in oncology research in French-speaking Switzerland
Presenter: Sara Colomer-Lahiguera
Session: Professional and educational issues in cancer nursing
Resources:
Abstract
1736MO - Pure or mixed basal/squamous tumours present decreased outcomes after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial
Presenter: Clarice Groeneveld
Session: Mini Oral session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: ESMO meets pharma: Next frontiers in drug discoveries
Resources:
Webcast
Risk stratified approach to cancer screening
Presenter: Partha Basu
Session: How advances in biology and technology are transforming the field of cancer prevention & early detection
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Boris Hadaschik
Session: Prostate-specific membrane antigen (PSMA) biology, diagnostics and treatment
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Justin Jeon
Session: Leveraging biology and technology to improve symptoms and quality of life of cancer survivors
Resources:
Slides
Webcast
140MO - HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analysis from the PerELISA trial
Presenter: Valentina Guarneri
Session: Mini Oral session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
890MO - Mutation spectrum in liquid versus solid biopsies from advanced digestive neuroendocrine carcinoma patients
Presenter: Halfdan Sorbye
Session: Mini Oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
CN43 - Addressing the professional and educational issues for the cancer nursing and allied health professions workforce: A collaborative, strategic, UK-wide approach
Presenter: Mark Foulkes
Session: Professional and educational issues in cancer nursing
Resources:
Abstract
1737MO - Tumor and immune features associated with disease-free survival with adjuvant nivolumab in the phase III CheckMate 274 trial
Presenter: Andrea Necchi
Session: Mini Oral session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast